High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC. - Frigola J; Carbonell C; Irazno P; Pardo N; Callejo A; Cedres S; Martinez-Marti A; Navarro A; Soleda M; Jimenez J; Hernandez-Losa J; Vivancos A; et al. (Journal for immunotherapy of cancer, 2022)